Spots Global Cancer Trial Database for leukemia lymphocytic acute (all) in relapse
Every month we try and update this database with for leukemia lymphocytic acute (all) in relapse cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| CRISPR (HPK1) Edited CD19-specific CAR-T Cells (XYF19 CAR-T Cells) for CD19+ Leukemia or Lymphoma. | NCT04037566 | Leukemia Lympho... Leukemia Lympho... Lymphoma, B-Cel... CD19 Positive | XYF19 CAR-T cel... Cyclophosphamid... Fludarabine | 18 Years - 55 Years | Xijing Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
